Please login to the form below

Proteostasis Therapeutics

This page shows the latest Proteostasis Therapeutics news and features for those working in and with pharma, biotech and healthcare.

AbbVie and C2N take tau antibody into clinic

Other companies working on tau as a target include TauRx Therapeutics, which has a phase III trial ongoing of its lead candidate LTX in Alzheimer's and is due to report ... Meanwhile, Biogen licensed rights to a tau-targeting compound in development at

Latest news

Astellas earmarks up to $1.2bn for protein folding research

Astellas has teamed up with US company Proteostasis Therapeutics to investigate new ways of treating diseases caused by protein defects, an emerging field of pharmaceutical research. ... Astellas will work with Proteostasis initially on one undisclosed
Elan and Proteostasis partnership

Elan and Proteostasis partnership. Elan Corporation has announced it is to partner with Proteostasis Therapeutics on a platform to discover and develop small molecule drugs and diagnostics for the treatment of ... Elan Corporation has announced it is to

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest Intelligence

Deal Watch table for November 2014

Company divestment. 1, 530. Proteostasis Therapeutics / Astellas. Therapeutics modulating Unfolded Protein Response - multiple programmes. ... Cerdelga (eliglustat) sold by Vertex. Acquisition 75% royalty stream. 66. Five Prime Therapeutics / BMS.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Proteostasis Therapeutics strengthens leadership team

Proteostasis Therapeutics strengthens leadership team. James DeTore, Geoffrey Gilmartin and Marija Zecevic join. ... Cambridge, Massachusetts-based Proteostasis Therapeutics has bolstered its leadership team with three new appointments.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Medical Writer - (London, Brighton or Copenhagen): Competitive

Senior Medical Writer: Great salary and bebefits

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Senior Account Manager or AD - Medical Communications: Salary TBC

Account Manager – Med Comms – London: Salary TBC

Senior Programme Executive: Salary TBC

Senior Account Manager / Account Director: Great salary and bebefits

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Senior Account Manager – Med Comms – Kent: Salary TBC

Senior Medical Writer: Great salary and benefits

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Editorial Director – Medical Education – Oxford: Negotiable

Editor – Medical Education Agency – Bucks: Salary TBC

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Scientific Director: Great salary and bebefits

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Subscribe to our email news alerts

PMHub

Add my company

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...